Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Intas Pharmaceuticals files IPO papers with SEBI

    Intas Pharmaceuticals that engaged in the development, manufacture and marketing of pharmaceutical formulations has filed IPO papers with SEBI.
    June 20, 2013 / 13:14 IST

    Gujarat-based Intas Pharmaceuticals has filed draft red herring prospectus (DRHP) with market regulator SEBI to list its public issue on exchanges.

    Intas Pharmaceuticals is engaged in the development, manufacture and marketing of pharmaceutical formulations.

    Healthcare firm intends to use issue proceeds for marketing authorization expenses; setting up of research and development facility; and general corporate purposes.

    Equity shares are proposed to be listed on the NSE and the BSE.

    Kotak Mahindra Capital Company Limited and Morgan Stanley India Company Private Limited are the book running lead managers, however Link Intime India Private Limited is the registrar to the issue.

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347